Sign In
Buy MBII
$0.798
+0 (+0%)
At Close: Nov 04, 2022
Two Marrone Bio Products Appear On EPA Site Of Approved Hemp Pesticides
12:00am, Thursday, 19'th Dec 2019MBII: Marrone Bio Innovations announces the results of a next generation nematicide/insecticide, MBI-306.
12:00am, Wednesday, 18'th Dec 2019Burnout Is About Your Workplace, Not Your People
01:05pm, Wednesday, 11'th Dec 2019
Leaders create the conditions that lead to burnout — or prevent it.
MBII: Marrone Bio Innovations reports results of nematode control on corn and improved stress tolerance on barley and wheat.
12:00am, Tuesday, 10'th Dec 2019Marrone Bio Innovations Announces Plans for CEO Succession
12:00am, Monday, 02'nd Dec 2019Small firms are a part of the big picture in innovation
01:01pm, Tuesday, 26'th Nov 2019
X-ray technology firm Micro-X proves that small firms can punch above their weight in the collaborative effort to build defence capability.
Micro-X hones in on equity raising
09:55am, Sunday, 17'th Nov 2019
Stockbroker Morgans is expected to close the books on an equity raising for lightweight X-ray products maker Micro-X.
Marrone Bio Innovations, Inc. (MBII) CEO Pam Marrone on Q3 2019 Results - Earnings Call Transcript
12:00am, Wednesday, 13'th Nov 2019Marrone’s New Bioherbicide Shows Promise in Palmer Amaranth Fight
03:08pm, Tuesday, 12'th Nov 2019
Marrone Bio Innovations has discovered positive results in 2019 field trials for its new bioherbicide, MBI-015.
